Prognostic Significance of Achieving the Radical Cystectomy‐Pentafecta After Neoadjuvant Chemotherapy and Robot‐Assisted Radical Cystectomy
International Journal of Urology · 2026
DOI: 10.1111/iju.70283 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Urology, 2026. Verfasst von Kyotaro Fukuta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan. Hauptthemen laut MEDLINE: Cystectomy, Robotic Surgical Procedures, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
This collaborative, multi‐institutional retrospective study aimed to evaluate whether achieving the radical cystectomy‐pentafecta contributes to improved outcomes in patients with muscle‐invasive bladder cancer undergoing neoadjuvant chemotherapy followed by robot‐assisted radical cystectomy.
Methods
We retrospectively analyzed 195 patients with muscle‐invasive bladder cancer who underwent robot‐assisted radical cystectomy with intracorporeal urinary diversion at four affiliated institutions. All had a minimum follow‐up of 12 months. According to previously established criteria, patients who simultaneously demonstrated (i) negative soft tissue surgical margins, (ii) ≥ 16 lymph node yield, (iii) absence of major complications at 90 days, (iv) absence of urinary diversion‐related long‐term sequelae, and (v) absence of clinical recurrence in the first year were considered to have achieved the radical cystectomy‐pentafecta.
Results
The overall radical cystectomy‐pentafecta achievement rate was 46.2% (46.5% in the neoadjuvant chemotherapy group and 45.3% in the no chemotherapy group). In the neoadjuvant chemotherapy group, patients who achieved the radical cystectomy‐pentafecta demonstrated significantly better overall survival ( p = 0.038), cancer‐specific survival ( p = 0.009), and recurrence‐free survival ( p < 0.001) than those who did not.
Conclusions
The radical cystectomy‐pentafecta is a valuable tool to assess the quality of robot‐assisted radical cystectomy with intracorporeal urinary diversion. Its achievement may be associated with improved outcomes in patients with muscle‐invasive bladder cancer undergoing neoadjuvant chemotherapy prior to surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
- Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
- Department of Urology, Takamatsu Red Cross Hospital, Kagawa, Japan.
- Department of Urology, Ehime Prefectural Central Hospital, Ehime, Japan.
ORCID-Profile: Kyotaro Fukuta, Yutaro Sasaki, Keito Shiozaki, Tomoya Fukawa, Junya Furukawa
Zitieren
APA
Fukuta, K., Sasaki, Y., Daizumoto, K., Izumi, K., Kadoriku, F., Utsunomiya, S., Shiozaki, K., Nakashima, T., Fukawa, T., Nakanishi, R., Izaki, H., & Furukawa, J. (2026). Prognostic Significance of Achieving the Radical Cystectomy‐Pentafecta After Neoadjuvant Chemotherapy and Robot‐Assisted Radical Cystectomy. International Journal of Urology. https://doi.org/10.1111/iju.70283
Vancouver
Fukuta K, Sasaki Y, Daizumoto K, Izumi K, Kadoriku F, Utsunomiya S, et al. Prognostic Significance of Achieving the Radical Cystectomy‐Pentafecta After Neoadjuvant Chemotherapy and Robot‐Assisted Radical Cystectomy. International Journal of Urology. 2026. doi:10.1111/iju.70283
BibTeX
@article{Fukuta2026,
author = {Fukuta, Kyotaro and Sasaki, Yutaro and Daizumoto, Kei and Izumi, Kazuyoshi and Kadoriku, Fumiya and Utsunomiya, Seiya and Shiozaki, Keito and Nakashima, Takeshi and Fukawa, Tomoya and Nakanishi, Ryoichi and Izaki, Hirofumi and Furukawa, Junya},
title = {Prognostic Significance of Achieving the Radical Cystectomy‐Pentafecta After Neoadjuvant Chemotherapy and Robot‐Assisted Radical Cystectomy},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70283}
}
EUVIMED